{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:02:41Z","timestamp":1793721761233,"version":"4.6.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Mermaid"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) vaccination has shown high efficacy against anal HPV infection and lesions in clinical trials, and the HPV prevalence and type distribution in anal precancers and cancer predict a high preventable potential for HPV vaccination. However, the real-world effectiveness of HPV vaccination against anal high-grade lesions and cancer is yet to be shown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated HPV vaccine effectiveness against anal high-grade squamous intraepithelial lesion (HSIL) or worse in a nationwide cohort including all Danish women aged 17-32\u2009years during October 2006 to December 2021 (n\u2009=\u2009968\u200a881). HPV vaccinations and first occurrence of anal HSIL or worse were retrieved from nationwide registries. Women were considered vaccinated after first dose and classified by age at vaccination. Using Cox regression, hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for anal HSIL or worse according to vaccination status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, the number of incident histological anal HSIL or worse cases was 37 in unvaccinated women, and less than 5 and 26 in women vaccinated at ages younger than 17\u2009years and 17-32\u2009years, respectively. The overall number of cancers was less than 5. Compared with unvaccinated women, the risk of histological anal HSIL or worse was reduced for women vaccinated at age younger than 17\u2009years (HR\u2009=\u20090.30, 95% CI = 0.10 to 0.87). For women vaccinated at age 17-32\u2009years, the hazard rate of anal HSIL or worse was 1.21 (95% CI = 0.73 to 2.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first study to demonstrate that HPV vaccination at a younger age is associated with substantially reduced risk of anal HSIL or worse in the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djad189","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T09:57:46Z","timestamp":1694167066000},"page":"283-287","source":"Crossref","is-referenced-by-count":34,"title":["Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer\u2014a real-world effectiveness study"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-5169","authenticated-orcid":false,"given":"Louise","family":"Baandrup","sequence":"first","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes, Danish Cancer Institute , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Maltesen","sequence":"additional","affiliation":[{"name":"Statistics and Data Analysis, Danish Cancer Institute , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dehlendorff","sequence":"additional","affiliation":[{"name":"Statistics and Data Analysis, Danish Cancer Institute , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K","family":"Kjaer","sequence":"additional","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes, Danish Cancer Institute , Copenhagen, Denmark"},{"name":"Department of Gynaecology, Rigshospitalet, University of Copenhagen , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"2024020820183237600_djad189-B1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"2024020820183237600_djad189-B2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"2","key":"2024020820183237600_djad189-B3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"2024020820183237600_djad189-B4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur J Cancer"},{"key":"2024020820183237600_djad189-B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2019.04.032","article-title":"Human papillomavirus vaccination: The ESGO-EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy","volume":"116","author":"Joura","year":"2019","journal-title":"Eur J Cancer"},{"issue":"7","key":"2024020820183237600_djad189-B6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: Nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2024020820183237600_djad189-B7","doi-asserted-by":"crossref","first-page":"djt460","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia\u2013nationwide follow-up of young Danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2024020820183237600_djad189-B8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"2024020820183237600_djad189-B9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10316","key":"2024020820183237600_djad189-B10","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"2024020820183237600_djad189-B11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jnci\/djaa209","article-title":"Real-world effectiveness of Human Papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers","volume":"113","author":"Dehlendorff","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1403494810394718","article-title":"The Danish National Health Service Register","volume":"39","author":"Andersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish Education Registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"suppl 7","key":"2024020820183237600_djad189-B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2024020820183237600_djad189-B18","author":"Statens Serum Institut"},{"key":"2024020820183237600_djad189-B19","author":"Statens Serum Institut"},{"issue":"7","key":"2024020820183237600_djad189-B20","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.vaccine.2019.12.019","article-title":"Resilience of HPV vaccine uptake in Denmark: decline and recovery","volume":"38","author":"Hansen","year":"2020","journal-title":"Vaccine"},{"key":"2024020820183237600_djad189-B21","author":"R Core Team","year":"2017"},{"issue":"3","key":"2024020820183237600_djad189-B22","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2024020820183237600_djad189-B23","doi-asserted-by":"crossref","first-page":"102099","DOI":"10.1016\/j.canep.2022.102099","article-title":"Trends in incidence and survival from anal cancer and incidence og high-grade anal intraepithelial neoplasia in Denmark","volume":"77","author":"Urbute","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2024020820183237600_djad189-B24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"issue":"suppl 2","key":"2024020820183237600_djad189-B25","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciac044","article-title":"Anal cancer screening and prevention: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infection guidelines","volume":"74","author":"Barroso","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024020820183237600_djad189-B26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial","volume":"12","author":"Kreimer","year":"2011","journal-title":"Lancet Oncol"},{"issue":"17","key":"2024020820183237600_djad189-B27","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2024020820183237600_djad189-B28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(21)00327-3","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: Results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Goldstone","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"2024020820183237600_djad189-B29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/ciab434","article-title":"High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with human immunodeficiency virus","volume":"73","author":"Palefsky","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024020820183237600_djad189-B30"},{"issue":"47","key":"2024020820183237600_djad189-B31","first-page":"3254","article-title":"[\u2018\u2018Liva\u201d\u2013population survey of female sexual habits]","volume":"172","author":"Olesen","year":"2010","journal-title":"Ugeskr Laeger"},{"issue":"10","key":"2024020820183237600_djad189-B32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djab081","article-title":"Real-world HPV vaccine effectiveness studies: guideposts for interpretation of current and future studies","volume":"113","author":"Campos","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"2024020820183237600_djad189-B33","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"2024020820183237600_djad189-B34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jadohealth.2014.12.008","article-title":"Socioeconomic predictors of human papillomavirus vaccination among girls in the Danish childhood immunization program","volume":"56","author":"Slattelid Schreiber","year":"2015","journal-title":"J Adolesc Health"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad189\/52460803\/djad189.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/2\/283\/56626074\/djad189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/2\/283\/56626074\/djad189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T15:18:56Z","timestamp":1707405536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/2\/283\/7274817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2024,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad189","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,9,18]]}}}